Intrinsic value of Evaxion Biotech A/S (EVAX)

Live fair value data for Evaxion Biotech A/S (EVAX) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Upside: +51.0%

Margin of Safety: +33.8%

Current Price: $48.00

Valuation: Undervalued

Confidence: 9.5/10

Visual Bar

Market Price $48.00Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Intrinsic Value checker

Enter any ticker to open its intrinsic value analysis page.

Is Evaxion Biotech A/S (EVAX) undervalued or overvalued?

Based on the current model output, Evaxion Biotech A/S appears to be undervalued with a upside of 51.00%.

Fair value vs market price — Evaxion Biotech A/S (EVAX)

Unlock premium access to view the live fair value comparison against current market price for EVAX.

Frequently Asked Questions - EVAX

How is EVAX intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for EVAX.

Is EVAX undervalued or overvalued right now?

EVAX is currently shown as undervalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for EVAX: open their intrinsic value pages.

Explore Other Stocks